biotech news today obesity drugs glp-1 Lilly orforglipron oral phase 3 weight loss trial Chinese Biotech Takes Aim At

Clefts are often classified into two groups: syndromic (30%) and nonsyndromic (70%)

It is popular and well known for its ability to convert fat into energy

Side effects should primarily be positive: Meaning an increase in energy levels, decrease in crashes, improvement in hair growth (or decrease in hair loss), improved concentration, decreased depression, etc

Research on MOTS-c in ovariectomized mice (a model for postmenopausal metabolic dysfunction) showed reduced fat accumulation in white adipose tissue, increased brown fat activation, and improved insulin sensitivity after just 5 weeks of treatment

DES(1-3) IGF-1 is not separately enumerated on the WADA Prohibited List as of the 2026 iteration, although the WADA S2 category includes language covering "any substance with similar chemical structure or similar biological effect(s)," which would encompass IGF-1 analogues broadly